Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,330 public trials 286 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 51 locations
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 21 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

NCT05663515

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Research Site Copenhagen, Denmark
  • Research Site Helsinki, Finland
  • Research Site Paris, France
  • Research Site Bergen, Norway
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07252232

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 78 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

NCT07409272

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Mercy Cancer Center Fort Smith, Arkansas, United States
  • Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton Fullerton, California, United States
  • Cedars-Sinai - Cedars-Sinai Medical Center Los Angeles, California, United States
View all 79 locations
View Trial Details
Recruiting

UCSF PANC Cyst Registry

NCT04291651

Conditions
Adenoma, Cystadenoma, Cystadenoma, Serous, +21 more
Locations
  • University of California, San Francisco San Francisco, California, United States
View Trial Details

Related conditions